Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision notes updated: v3.3.4 added and v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a Florida location to the study Locations section and removed the separate Florida Locations entry; page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:25:20.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The Publications section now clarifies that publications are provided voluntarily and relate to the study results. A revision note 'Revision: v3.3.2' was added.
    Difference
    0.1%
    Check dated 2025-11-24T21:59:08.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A government funding/operating status notice was removed from the page. The study details, eligibility criteria, and outcomes sections appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T20:09:30.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    No significant updates to the study details or results are visible; any differences appear to be minor formatting changes, and to avoid alerts for small changes, set an alert condition.
    Difference
    0.4%
    Check dated 2025-11-03T14:22:28.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Major change: page version upgraded to v3.2.0 and added a government-operating status notice; minor content addition of a medical term (Soft tissue sarcoma). Deletion of v3.1.0 confirms version update. If no other core content changes are detected, this is a partial but notable update.
    Difference
    3%
    Check dated 2025-10-06T04:27:23.000Z thumbnail image

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.